IDEAS home Printed from https://ideas.repec.org/a/zib/zbnmsp/v2y2018i1p19-22.html
   My bibliography  Save this article

Renal Clearance And Urinary Excretion Of Moxifloxacin In Healthy Male Volunteers

Author

Listed:
  • Asia Farid

    (Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Faisalabad, Pakistan)

  • Tanweer Khaliq

    (Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Faisalabad, Pakistan)

  • Hafiz Alam Sher

    (Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Faisalabad, Pakistan)

  • Atifa Mushtaq

    (Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Faisalabad, Pakistan)

  • Abdullah Abid

    (Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Faisalabad, Pakistan)

Abstract

Moxifloxacin is a 4th generation fluoroquinolone. Study was planned on renal clearance and urinary excretion of moxifloxacin on healthy male volunteers by applying sensitive, rapid and accurate HPLC-UC analytical method. For this study 8 healthy male subjects similar in all physical conditions were selected. Moxifloxacin (Avelox® 400 mg) was administered orally under fasting conditions. First sample of urine and blood was collected before administration of moxifloxacin and other samples of blood were taken at 0.5, 1.5, 2.5, 3.5 hr and urine samples were withdrawn at 1, 2, 3, 4, 6, 8, 10, 12, 24, 36 and 48 hr. The pH of the samples was measured by pH meter. Blood and urine samples were analyzed with HPLC for drug determination. Endogenous creatinine was measured by reagent kit method. The plasma concentration of endogenous creatinine and drug were 12.61 ± 0.85 µg/mL and 1.678 ± 0.062 µg/mL. The renal clearance of endogenous creatinine ranges from 1.17 to 3.18 ml/min/kg with an average ± SE value of 2.67 ± 0.24 mL/min/Kg. Renal clearance of moxifloxacin was 0.476 ± 0.04 mL/min/Kg ranged between 0.27 – 0.609 mL/min/Kg. Urinary excretion of moxifloxacin calculated as cumulative percent dose excreted 20.48 ± 0.88. A positive relationship was found between diuresis and renal clearance of drug indicated that besides glomerular filtration passive diffusion is also involved at kidney tubular level.

Suggested Citation

  • Asia Farid & Tanweer Khaliq & Hafiz Alam Sher & Atifa Mushtaq & Abdullah Abid, 2018. "Renal Clearance And Urinary Excretion Of Moxifloxacin In Healthy Male Volunteers," Matrix Science Pharma (MSP), Zibeline International Publishing, vol. 2(1), pages 19-22, January.
  • Handle: RePEc:zib:zbnmsp:v:2:y:2018:i:1:p:19-22
    DOI: 10.26480/msp.01.2018.19.22
    as

    Download full text from publisher

    File URL: https://matrixscpharma.com/download/688/
    Download Restriction: no

    File URL: https://libkey.io/10.26480/msp.01.2018.19.22?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zib:zbnmsp:v:2:y:2018:i:1:p:19-22. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Zibeline International Publishing (email available below). General contact details of provider: https://matrixscpharma.com/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.